Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00973804
What this trial is testing

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Who this might be right for
LeukemiaNon-Hodgkins LymphomaHodgkins Lymphoma+2 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03821610
What this trial is testing

A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)

Who this might be right for
Acute Lymphoblastic Leukemia
University of Birmingham 242
Early research (Phase 1)Looking for participantsNCT05757310
What this trial is testing

A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia

Who this might be right for
Recurrent Severe Aplastic AnemiaRefractory Severe Aplastic Anemia
City of Hope Medical Center 6
Testing effectiveness (Phase 2)UnknownNCT00750126
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Solid TumorsHematologic Neoplasms
University Hospital, Clermont-Ferrand 30
Not applicableActive Not RecruitingNCT04167683
What this trial is testing

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Who this might be right for
Hematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more
Rigshospitalet, Denmark 144
Testing effectiveness (Phase 2)Study completedNCT01572181
What this trial is testing

Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens

Who this might be right for
Hematologic Malignancy
Nantes University Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT00548717
What this trial is testing

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-vs-Host Disease
Dana-Farber Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT01188174
What this trial is testing

Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure

Who this might be right for
AML
Nantes University Hospital 26
Testing effectiveness (Phase 2)Looking for participantsNCT03520647
What this trial is testing

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Who this might be right for
Severe Aplastic Anemia (SAA)Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)
National Heart, Lung, and Blood Institute (NHLBI) 56
Early research (Phase 1)Study completedNCT00079625
What this trial is testing

Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Looking for participantsNCT05436418
What this trial is testing

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Who this might be right for
Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 260
Early research (Phase 1)Ended earlyNCT05298358
What this trial is testing

RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Early research (Phase 1)Ended earlyNCT00684255
What this trial is testing

Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis
New York Medical College 1
Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Early research (Phase 1)UnknownNCT00006347
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Testing effectiveness (Phase 2)Study completedNCT03263559
What this trial is testing

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

Who this might be right for
Sickle Cell Disease
Medical College of Wisconsin 95
Testing effectiveness (Phase 2)Study completedNCT01162096
What this trial is testing

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Testing effectiveness (Phase 2)WithdrawnNCT00004878
What this trial is testing

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01392989
What this trial is testing

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Who this might be right for
Neural Tube DefectsAnemiaLeukemia, Myeloid+3 more
Everett Meyer 44
Not applicableUnknownNCT00898118
What this trial is testing

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Working Group of MDS in Childhood 125
Next Page